Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd. > L2 looking hot again

<< Previous

Bullboard Posts

Next >>

Comment by mrnormalon Jul 21, 2020 11:52am

86 Views

Post# 31296444

RE:RE:L2 looking hot again

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders

$0.235	60000	3	$0.24	108500	6
$0.23	50500	6	$0.245	121500	16
$0.225	163000	20	$0.25	75500	14
$0.22	358500	16	$0.255	48500	7
$0.215	260000	15	$0.26	100500	6
$0.21	809500	10	$0.265	74500	5
$0.205	20000	8	$0.27	205500	9
$0.20	222500	13	$0.275	23500	6
$0.195	150500	19	$0.28	115000	7
$0.19	59000	5	$0.285	20500	4